Cargando…
Evaluation of the potential herb-drug interaction between Bojungikki-tang and PD-L1 immunotherapy in a syngeneic mouse model
Atezolizumab (a PD-L1 inhibitor) has shown remarkable efficacy and tolerability in various cancer types. Despite its efficacy and safety, atezolizumab monotherapy has limitations, such as acquired resistance and adverse events. Bojungikki-tang (BJIKT) is an herbal decoction widely prescribed in Asia...
Autores principales: | Yang, Sung-Yoon, Yi, Jin-Mu, Chun, Jaemoo, Park, Seongwon, Bui, Tham Thi, Yun, Hwi-Yeol, Chae, Jung-Woo, Jeong, Mi-Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232755/ https://www.ncbi.nlm.nih.gov/pubmed/37274110 http://dx.doi.org/10.3389/fphar.2023.1181263 |
Ejemplares similares
-
Bojungikki-Tang Improves Response to PD-L1 Immunotherapy by Regulating the Tumor Microenvironment in MC38 Tumor-Bearing Mice
por: Chun, Jaemoo, et al.
Publicado: (2022) -
Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial
por: Ko, Mi Mi, et al.
Publicado: (2023) -
Differential Regulation of NF-κB and Nrf2 by Bojungikki-Tang Is Associated with Suppressing Lung Inflammation
por: Park, Soo Ryun, et al.
Publicado: (2018) -
Study of Pharmacodynamic and Pharmacokinetic Interaction of Bojungikki-Tang with Aspirin in Healthy Subjects and Ischemic Stroke Patients
por: Yoo, Jung-Hwa, et al.
Publicado: (2018) -
Protective Effect of Bojungikki-Tang against Radiation-Induced Intestinal Injury in Mice: Experimental Verification and Compound-Target Prediction
por: Kang, Sohi, et al.
Publicado: (2023)